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Abstract
The Hippo pathway has recently been implicated in the regulation of organ size and stem cells in multiple tissues. The
transcriptional cofactor yes-associated protein 1 (Yap1) is the most downstream effector of Hippo signaling and is
functionally repressed by the upstream components of the pathway. Overexpression of YAP1 stimulates proliferation of
stem and progenitor cells in many tissues, consistent with inhibition of Hippo signaling. To study the role of Hippo signaling
in hematopoietic stem cells (HSCs), we created a transgenic model with inducible YAP1 expression exclusively within the
hematopoietic system. Following 3 months induction, examination of blood and bone marrow in the induced mice revealed
no changes in the distribution of the hematopoietic lineages compared to control mice. Moreover, the progenitor cell
compartment was unaltered as determined by colony forming assays and immunophenotyping. To address whether YAP1
affects the quantity and function of HSCs we performed competitive transplantation experiments. We show that ectopic
YAP1 expression does not influence HSC function neither during steady state nor in situations of hematopoietic stress. This
is in sharp contrast to effects seen on stem- and progenitor cells in other organs and suggests highly tissue specific
functions of the Hippo pathway in regulation of stem cells.
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Introduction
The first components of the Hippo tumor suppressor pathway
were discovered two decades ago in Drosophila mosaics studies as
regulators of cell shape and cell proliferation [1,2]. Subsequently,
all the major cytosolic components have been established and the
pathway is now understood to be organized as a kinase-signaling
cascade that negatively regulates the downstream effector Yorkie
[3]. The function of the pathway is largely evolutionary conserved
and mammalian homologs corresponding to all Drosophila Hippo
proteins have been identified [4,5,6].
As homologs of Drosophila Hippo (Hpo), the mammalian
STE20-like protein kinase 1 and 2 (Mst1/2) make up one of the
two core kinase groups in the Hippo pathway. Mst is stabilized by
interacting with the Salvador homolog 1 (Sav1) and activates the
downstream large tumor suppressor homolog 1 and 2 (Lats 1/Lats
2) via phosporylation [7]. Lats 1/2 interact with Mps One Binder
kinase activator-like (Mob1), homolog of the Drosophila mats, and
then in turn phosphorylate the Yorkie homolog Yes associated
protein 1 (Yap1). Phosphorylated Yap1 contains a binding site for
14-3-3 proteins, which promotes cytosolic retention and prevents
Yap from translocating to the nucleus [5,8]. Both the Drosophila
Yorkie and its mammalian homolog Yap1, contain highly
conserved WW-domains. These domains recognize proline-rich
motifs facilitating protein–protein interactions [9]. In the nucleus,
Yap1 functions as a transcriptional coactivator, initiating tran-
scription in complex with various transcription factors, such as
p73, EGR-1, Runx 1/2 and particularly the TEA domain (TEAD)
family [10,11]. The interactions with TEAD transcription factors
are the only known interactions conserved from Drosophila to
mammals [12]. A main biological function of Yap1 is to promote
cell proliferation through regulation of cell cycling and apoptosis.
These functions are thus counteracted by the upstream Hippo
components, resulting in a tight regulation of tissue homeostasis, as
demonstrated in mouse models of altered Hippo signaling. Zhou
and colleagues established that combined Mst1/Mst2 deficiency in
the liver results in massive overgrowth and hepatocellular
carcinoma as the loss of Mst1/Mst2 signaling abrogates Yap1
phosphorylation, leading to enhanced Yap1 activity in the nucleus
and an increased transcriptional activity. Consistent with these
consequences of perturbed Hippo signaling, several studies have
demonstrated that overexpression of YAP1 in the liver results in a
dramatic increase in cell proliferation and organ size [4,13].
The profound role of Hippo signaling in regulating tissue
homeostasis across different species raises the possibility of a
functional importance in stem cells. In a transcriptional profiling
study by Ramalho-Santos et al, comparing embryonic, neural and
hematopoietic stem cells showed that Yap1 was one of a few genes
with a consistently higher expression across the stem cell fractions
compared to differentiated cells [14]. More recently, these
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Yap1 in various stem cell types where Yap1 has been established
as a vital factor in stem cell maintenance and proliferation. Cao
and colleagues showed that YAP1 regulates neural progenitor cell
number in the chick neural tube [15]. It was further demonstrated
that Yap1 is necessary for maintained pluripotency in murine
embryonic stem (ES) cells and that ectopic expression of YAP1
prevents ES cell differentiation [16,17]. Finally, overexpression of
YAP1 in the mouse intestine leads to expansion of multipotent
progenitors [13]. Taken together, this provides evidence that
YAP1 functions as a stem cell regulator.
While the Hippo pathway and Yap1 has been extensively
studied in other tissues, its function in the hematopoietic system
remains largely unknown. Here we study the role of Hippo
signaling in hematopoiesis by conditionally overexpressing YAP1
within the hematopoietic system in vivo.
Methods
Ethics statement
This study was carried out in strict accordance with the
recommendations in the Guide for the Care and Use of
Laboratory Animals of the National Institutes of Health. All
animal experiments were reviewed and approved by the Lund/
Malmo ¨ Local Ethical committee as defined in the ethical permit
with number M217-09.
Tet-YAP vector construction
The tet-YAP expression vectors was constructed using wildtype
human YAP1 cDNA (5747370, Open Biosystems) and YAP1 DNA
synthesized with a Serine 127 to Alanine mutation (ATG:biosyn-
thetics GmbH, Merzhausen, Germany). Both were inserted into the
pBS31 targeting vector using EcoRI and MluI restriction sites [18].
ES cell culture and gene targeting
Embryonic stem cell line KH2 [18] was cultured on irradiated
murine embryonic fibroblast (MEF) cells according to standard
procedure. Briefly, cells were seeded at a density of 3610
4 cells/cm
2
in DMEM supplemented with LIF at 1000 units/ml (ESGROH,
Millipore), 15% ES qualified fetal bovine serum, non essential
amino acids and sodium pyruvate (GIBCO), and passaged every
otherday.Genetargetingwasperformedasfollows;tet-YAPvectors
were co-electroporated with a Flp recombinase-expressing vector,
pCAAGS-Flp, and seeded on MEFs. Colonies were picked
following 7 days of hygromycin selection and screened for
integration of the vector into the ColA1 locus with PCR primers:
tccctcacttctcatccagatatt, agtcttggatactccgtgaccata, ggacaggataagtat-
gacatcatcaa. YAP1 overexpression was induced with doxycycline at
a concentration of 1 mg/ml during 3 days.
Generation of tet-YAP1- fetal liver cells and YAP1
chimeric mice
A correctly targeted ES clone was injected into W
41/W
41
blastocysts (CD45.2, The Jackson Laboratory, Bar Harbor, USA)
and transferred to pseudo pregnant foster mothers. Fetal liver cells
were isolated from day 14.5 embryos as described before [19].
Lethally irradiated (900 cGy) C57bl/6/SJL mice (CD45.1, in-house
breeding) were then injected intravenously with 2610
6 unfraction-
ated fetal liver cells to generate primary tet-YAP1 chimeric mice.
Reconstitution was confirmed six weeks post-transplant where after
mice were induced during 12 or 15 weeks (wildtype and mutant
YAP1 respectively) by supplementing the drinking water with of
2 mg/ml doxycycline and 10 mg/ml sucrose. Secondary recipients
were transplanted with 2610
6 bone marrow cells from primary
mice and an identical number of competitor cells from congenic
C57Bl/66SJL (CD45.1/CD45.2, in-house breeding) mice.
Generation of YAP
mut germline mice
The verified tet-YAP
mut ES clone was injected into W41/W41
blastocysts, which were transferred into pseudo pregnant foster
mothers and carried to terms. Male mice from the litters were
crossed with C57/bl6 mice and progeny genotyped for the tet-
YAP
mut modification at the Cola1a locus (PCR primers same as
before) and the rtTa modification at the ROSA26 locus with PCR
primers: aaagtcgctctgagttgttat, gcgaagagtttgtcctcaacc, ggagcggga-
gaaatggatatg. Germline progeny was then further intercrossed to
produce mice with different combination of genotypes.
Real-time PCR
Whole bone marrow was isolated form C57BL/6 mice
(Taconic) and enriched for c-kit positive cells using CD117
MicroBeads and MACS separation columns (Miltenyi Biotec).
Cells were stained with antibodies against CD34, Flt3, Sca-1, c-kit
and lineage markers CD3, CD4, CD8, Gr1, Mac-1, B220 and
Ter119. All antibodies from Biolegend. Long-term HSCs (Lin-,
Sca-1+, c-kit+(LSK), Flt32, CD342), short-term HSCs (Lin2,
Sca-1+, c-kit+, Flt32, CD34+), lymphoid myeloid primed
progenitors (Lin2, Sca-1+, c-kit+, Flt3+, CD34+) and lineage
positive (Lin+) cells were sorted using the FACS Aria (Becton
Dickinson). RNA was isolated using the Mini RNAeasy kit
(Qiagen) and cDNA transcribed with SuperScript III reverse
trancriptase (Invitrogen). Real-time PCR was performed with the
Taqman Assay System and primer sets from Applied Biosciences.
Flow cytometry
Intracellular levels of YAP expression were measured with flow
cytometry using primary anti-YAP antibody from Cell Signaling
(#4912) and secondary anti-rabbit donkey Ig DyLight649
antibody (Biolegend). Cells were fixed with 4% paraformaldehyde
(Sigma) and permeabilized in 0,5% Saponin (Sigma).
Additional antibodies used for determining lineage distribution
and HSC immunophenotype were anti-CD45.1 and CD45.2
(Biolegend).
Colony forming assay
Wholebonemarrowcellsuspensionwasplated inmethylcellulose
medium (M3434, Stem Cell Technologies) and scored for colony
formation according to the manufacturer’s instruction. Doxycycline
was added to the medium at a concentration of 1 mg/ml.
Western blot
ES cells were resuspended in Laemli buffer (BioRad) according
to manufacturer’s instructions, denatured by heating at 95uC for
10 min and then centrifuged at 4uC. The supernatant was loaded
on NuPageH Gels and blotted using the iBlotH Dry Blotting system
(Invitrogen). Membranes were probed with primary antibody
against YAP1 (same as before) and a-tubulin (#7291,Abcam).
ECL
TM-HRP linked secondary antibody and Amersham
TM ECL
Plus detection kit were both from GE Healthcare. Fractionation of
nuclear fraction was performed as described before [20].
Results
Components of the Hippo signaling pathway are
expressed in HSPCs
Recent work has shown that Hippo signaling through Yap1
regulates a variety of tissue stem cells, as well as ES cells, by
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role of Yap1 in hematopoietic cells we first evaluated the presence
of components of the Hippo signaling pathway in different subsets
of bone marrow hematopoietic cells. We used RT-qPCR to
determine mRNA levels of the core components Lats1/2, Mst1/2,
Sav1 as well as Yap1 in long-term (LT) repopulating HSC, short-
term (ST) repopulating HSCs, lymphoid myeloid primed progen-
itors (LMPP) and mature, lineage positive cells. The upstream
kinases Lats1/2 and Mst1/2 as well as the WW domain Sav1 were
clearly detected across all these subsets (Figure 1A) in contrast to
Yap1 which was detected at low levels in LT-HSCs and was barely
detectable in the other subsets (Figure 1B). Thus, while all
components upstream of Yap1 show widespread expression in
hematopoietic cells, Yap1 expression is more restricted to the
primitive HSC fraction.
Generation of a model for inducible expression of YAP1
in the hematopoietic system
We next generated mice with inducible YAP1 overexpression in
hematopoietic cells. Targeting constructs containing either wild-
type YAP1 cDNA (YAP) or a constitutively active mutant
(YAP
mut, Figure S1A–B) under control of a tet-ON promoter
were integrated into the ColA1 locus of KH2 ES cells (Figure 2A)
as described before [18,21]. Doxycycline-inducible expression was
confirmed by flow cytometry (Figure S1C) and nuclear localization
of YAP1 was verified by Western blot on ES cell extracts
(Figure 2B). The wildtype and mutant human isoform were clearly
detected in both cytosolic and nuclear fractions when doxycycline
was added to the cultures (Figure 2B, Lane 2,4 and 6,8) consistent
with a high translation rate in the cytosol and translocation to the
nucleus. The wildtype isoform has a higher molecular weight than
the endogenous murine protein and the mutant isoform. Next, as
outlined in figure 2C, tet-YAP ES cells were injected into
blastocysts from the HSC-deficient W
41/41 strain and transferred
to foster mothers. We have previously demonstrated that W
41/
W
41 blastocyst complementation generates embryos with fetal liver
HSCs of practically pure ES cell origin [21]. Fetal liver cells were
transplanted into lethally irradiated recipients to generate cohorts
of mice with tet-YAP transgenic hematopoiesis (Figure 2C). This
model system allows for tightly controlled transgene expression
within the hematopoietic system including all HSCs [21]. After six
weeks, complete hematopoietic reconstitution from tet-YAP fetal
liver cells was confirmed in all mice (Figure 2D). Overexpression of
YAP1 in hematopoietic cells was verified in mice treated with
doxycycline using flow cytometry and Western blot (Figure 2E).
Expression specifically in the stem and progenitor compartments
was confirmed with RT-qPCR (Figure 2F). Furthermore, mice
that were followed for up to a year showed hematopoiesis of
complete transgenic origin (Figure 2G). Both the wildtype and
mutant YAP1 constructs showed the expected phenotypes when
expression was induced in other tissues (Figure S2) [4,13].
Normal hematopoiesis in YAP1 induced mice
To determine the consequences of enforced YAP1 expression
within the hematopoietic system, we analyzed the induced tet-YAP
mice after administering doxycycline for 12 weeks. Examination of
blood and bone marrow in the induced mice revealed no changes
in the distribution of the hematopoietic lineages compared to
control mice (Figure 3A). Moreover, no difference in the number
of colony forming progenitor cells was found (Figure 3B,C) and the
frequency of the LSK multipotent progenitor population and the
CD34 negative HSC population was unaltered (Figure 3D). Taken
together, the overall hematopoietic profile, based on analysis of
cell surface marker expression and progenitor assays was normal in
YAP1 induced mice.
Enforced expression of YAP1 does not alter HSC number
and function measured by competitive transplantation
To further investigate if YAP1 expression alters the number or
function of hematopoietic stem cells in vivo we performed
competitive transplantation experiments. Unfractionated bone
marrow cells from treated and control tet-YAP mice (expressing
the CD45.2 cell surface marker) were injected together with equal
numbers of wildtype competitor cells (expressing both CD45.1
and CD45.2) into lethally irradiated CD45.1 recipients to
determine if the frequency of functionally defined stem cells
was altered after YAP1 expression (Figure 3E). Since there is no
induction of YAP1 expression during regeneration in the
recipient mice, this setup confines the readout to an assessment
of the size of the HSC pool present in the tet-YAP mice before
transplantation. Analysis of donor contribution following long-
term reconstitution (Figure 3F) showed similar engraftment levels
between mice transplanted with cells from induced tet-YAP mice
and controls, demonstrating that overexpression of YAP1 had not
influenced the HSC pool size during steady-state hematopoiesis.
To further test the consequences of YAP1 overexpression on
HSC function during hematopoietic regeneration, we performed
competitive transplantations with cells from non-induced tet-YAP
mice into recipients that were administered doxycycline upon
transplantation (Figure 3G). However, we observed no difference
in reconstitution capacity between mice with enforced YAP1
expression and controls (Figure 3H). Thus, we conclude that
ectopic YAP1 expression does not influence HSC function,
neither during steady state, nor in situations of hematopoietic
stress.
Figure 1. Components of the Hippo signaling pathway are expressed in hematopoietic stem and progenitor cells. mRNA expression
levels of upstreams components of the Hippo pathway (A) and the downstream effector Yap1 (B) in different stem and progenitor compartments.
Values are normalized against Hprt1 for n=2 (A) and n=3 (B). Error bars represent SEM. Abbreviations: LT, long-term HSCs; ST, short-term HSCs;
LMPPs, lymphoid myeloid primed progenitor; Lin+, lineage positive.
doi:10.1371/journal.pone.0032013.g001
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active form of YAP1 does not alter HSC function
Since we did not observe a hematopoietic phenotype when
expressing wildtype YAP1, we thought it pertinent to investigate
the effect of a constitutively active version of YAP1 (YAP
mut) with
an abolished phosphorylation site [5]. It has been shown that
YAP1 activity is regulated by phosphorylation of a serine residue
(S127), which targets YAP1 for cytoplasmic sequestration and
degradation [22]. Using the same approach as for wildtype YAP1
we generated mice, with inducible expression of YAP1
mut within
the hematopoietic system, and administered doxycycline for 15
weeks. Employing equivalent analysis as for wildtype YAP1, we
found no significant difference in lineage distribution, colony
formation or number of progenitor cells in primary YAP1
mut mice
(Figure 4A–D). Furthermore, competitive transplantation experi-
ments showed that YAP1
mut had no effect on the quantity or
function of stem cells (Figure 4E–G).
Thus, in sharp contrast to what has been described for many
other tissue stem cells, increased YAP1 activity does not alter the
function of hematopoietic stem and progenitor cells.
Figure 2. Generation of a mouse model with inducible YAP1 overexpression in the hematopoietic system. (A) ES cell targeting vector
containing tetracycline inducible promoter driving hYAP cDNA expression. The vector was targeted to the Cola1a locus of the KH2 ES cell line using
flp/FRT recombination. The endogenous Rosa26 promoter drives expression of the M2rtTA transactivator. (B) Western blot depicting overexpression
of YAP1 in ES clones with wildtype (tet-YAP) or mutated constitutively active (tet-YAP
mut) cDNA. Cells were cultured with (+) or without (2)
doxycycline for 5 days and then harvested and separated into cytosolic (cy) and nuclear (nu) fractions. The membrane was probed with antibodies
against YAP1, Tata-binding-protein (TBP), and alpha-tubulin (a-Tub). The wildtype human YAP1 protein is a longer isoform and is represented by the
higher molecular weight band whereas the lower band represents the murine and mutant human protein. (C) An overview of the experimental
setup. Briefly, ES cells (CD45.2) were targeted with a tetracycline inducible YAP1 cDNA vector, injected into E3.5 blastocysts from W
41/W
41 mice and
then transferred to a foster mother. Fetal liver (FL) cells were isolated from E14.5 embryos and whole cell suspension was transplanted into irradiated
recipients (CD45.1), generating tet-YAP1 hematopoietic chimeras. (D) Representative example of reconstitution levels in control and doxycycline
treated tet-YAP1 chimeric mice. Bone marrow cells were stained for congenic markers CD45.2 for donor tet-YAP1 cells and CD45.1 for recipient mice.
(E) Analysis of expression levels of YAP1 in the bone marrow of control and doxycycline treated tet-YAP mice using intracellular flow cytometry (left
panel) and Western Blot (right panel). (F) Expression of YAP
mut mRNA was verified in sorted progenitor (LSK) and stem cell (LSK CD34
2) fractions
using RT-qPCR. (G) PCR confirmation of tet-YAP
mut donor chimerism in hematopoietic stem and progenitor cells .30 weeks after transplantation of
tet-YAP FL cells. Bone marrow cells were plated in methylcellulose medium and PCR was performed on individual colonies. A minimum of 24 colonies
was screened per mouse. Abbreviations: M2-rtTA, reverse tetracycline transactivator; Tet, tetracycline; ES cells, murine embryonic stem cells; FL, fetal
liver; LSK, Lineage negative, Sca1 positive, kit positive cells.
doi:10.1371/journal.pone.0032013.g002
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An increasing body of work, generated during recent years,
implicates Hippo signaling as a key determinant of stem cell
function and organ size in a variety of tissues [13,15,17]. This has
to a large extent been demonstrated in gain-of-function models
for YAP1, counteracting upstream Hippo signaling. To clarify
whether Hippo signaling plays a significant role in hematopoiesis
and in regulation of HSCs we have studied a mouse model for
inducible expression of YAP1 within the hematopoietic system.
We demonstrate here that enforced expression of neither wildtype
nor constitutively active YAP1 alters hematopoiesis or HSC
function in vivo. This is in sharp contrast to the effect seen on
stem- and progenitor cells in other organs such as the intestine, the
brain and the skin, and suggests highly tissue specific functions of
the Hippo pathway in regulating stem cells. Thus, while Yap1 has
Figure 3. Normal hematopoiesis in YAP1 induced mice. Irradiated mice were transplanted with tet-YAP1 fetal liver cells and analyzed after 12
weeks of doxycycline induction. (A) The distribution of different cell lineages in peripheral blood using flow cytometry. Myeloid cells were Mac-1, Gr1
positive; B cells B220 positive and T cells CD3 positive. (B) The total number of methylcellulose colonies per 20000 total bone marrow cells from
control and doxycycline treated mice. (C) The total number of methylcellulose colonies per 20000 total bone marrow cells from untreated tet-YAP1
mice with or without doxycycline in the medium. (D) The frequency of hematopoietic stem and progenitor cells in total bone marrow of mice after
YAP1 overexpression. (E) Functional analysis of the stem cell compartment in tet-YAP mice using competitive transplantations. Total bone marrow
cells (CD45.2) from tet-YAP1 reconstituted mice were transplanted into secondary recipients together with an equal number of wildtype competitor
cells (CD45.1/45.2) 12 weeks after doxycycline induction. (F) Cells from control and doxycycline treated mice were transplanted into irradiated
recipients without treatment and in paralell (G) control bone marrow cells were transplanted, with competitors, and the recipient mice were
administered doxycycline directly upon injection. (H) Engraftment levels in peripheral blood 14 weeks after transplantation of induced and un-
induced tet-YAP1 cells and (D) engraftment after transplantation of untreated tet-YAP1cells with doxycycline administration upon injection. Error bars
represent SEM for n=7 (A–D, G) and n=3 (H). Abbreviations: LSK, Lineage negative, Sca1 positive, kit positive cells.
doi:10.1371/journal.pone.0032013.g003
Normal HSC Function in Mice Overexpressing YAP1
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are clearly context dependent.
The Hippo pathway is connected to a number of different
upstream regulatory elements, most of which remain poorly
defined in mammalian cells. Cell-cell interactions that control cell
proliferation through contact-mediated inhibition has been
attributed to Hippo signaling [23]. However, a distinct property
of the hematopoietic system, distinguishing it from solid organs, is
the liquid nature of the tissue wherein the cells reside; blood and
bone marrow. While contact-mediated inhibition of cell prolifer-
ation is an important mechanism for controlling tissue homeostasis
and size of solid organs, this phenomenon may have a lesser
impact on cells in a liquid tissue. This may explain why YAP1
causes cell proliferation and overgrowth in solid tissues but not in
the hematopoietic system.
In mammalian cells one of the most well characterized
regulators upstream of the Hippo pathway is Neurofibromatosis
2/Merlin (Nf2/Mer). Nf2/Mer is required for contact inhibition in
Figure 4. Inducible tissue-restricted expression of a constitutive active form of YAP1 does not alter HSC function. Primary recipients
were transplanted with tet-YAP
mut fetal liver cells after 15 weeks of induction. (A) Lineage distribution in bone marrow of tet-YAP
mut mice. Myeloid
cells were Mac-1, Gr1 positive; B cells B220 positive and T cells CD3 positive. (B) Colony formation efficiency of tet- YAP
mut bone marrow cells (C)
Colony formation from tet-YAP
mut cells with doxycycline added to the methylcellulose medium. (D) Immunophenotyping of progenitor and stem cell
compartement using flow cytometric analysis of primary mice (E). For the functional analysis of hematopoietic stem cell quantity cells from control
and doxycycline treated mice were transplanted into irradiated recipients without treatment. (F) In parallel, to evaluate hematopoietic stem cell
regeneration, control bone marrow cells were transplanted with competitors, and the recipient mice were administered doxycycline directly upon
injection. (G) Reconstitution of tet-YAP1
mut cells, treated and untreated, in peripheral blood after 30 weeks. (G) Percent tet-YAP
mut cells in the bone
marrow of recipients 30 weeks after transplantation with induction upon transplantation. Error bars represent SEM for n=5 (A–F), n=3–4 (G) and
n=5(H). Abbreviations: LSK, Lineage negative-Sca1 positive-kit positive cells.
doi:10.1371/journal.pone.0032013.g004
Normal HSC Function in Mice Overexpressing YAP1
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depletion in the liver causes a similar overgrowth phenotype as
seen in livers of Mst1/Mst2 knockout mice or mice with ectopic
expression of YAP1 [24]. By contrast, Nf2 depletion in
hematopoietic cells has no cell autonomous effects on HSCs or
progenitor cells, which is consistent with our observations of YAP1
overexpression in hematopoiesis [25]. However, Nf2 deficiency
has profound consequences on several non-hematopoietic com-
ponents of the bone marrow microenvironment, which is
manifested by dysregulation of stroma cells, endothelium and
bone, leading to secondary effects on localization and function of
HSCs [25]. It is an interesting possibility that Nf2/Mer functions
through Hippo signaling in this context, and it would therefore be
of considerable interest to explore the role of YAP1 within the
non-hematopoietic cells of the bone marrow microenvironment.
Although it is clear that increased YAP1 activity does not
influence HSCs during conditions of steady state and regeneration,
we cannot exclude changes in the HSC compartment that would
have consequences under conditions of severe hematopoietic
stress. When analyzing the expression of potential target genes in
YAP
mut induced LSK cells we noted a down modulation of the cell
cycle inhibitor p21 (data not shown). HSCs from mice lacking p21
show essentially normal function, but following severe hemato-
poietic stress by multiple serial transplantations become gradually
exhausted [26]. Whether YAP1 induction and decreased p21, in
that context, would influence the HSC pool remains to be
investigated.
While our findings indicate that YAP1 does not affect HSC
function, it is possible that a downstream mediator of the Hippo
pathway, other than Yap1, is active in hematopoietic cells. In
Drosophila, the Yap1 homolog Yorkie is the only known effector in
the Hippo pathway. In mammalian cells, however, the evolution-
ary divergent Yap1 paralog Taz (Wwtr1) has partially overlapping
functions with Yap1, forming complexes with TEAD transcription
factors and mediates cell proliferation [27]. It has, however, been
demonstrated that Yap and Taz has several distinct functions that
are dependent on species and tissue type [28,29,30]. Consequent-
ly, it would be interesting to investigate whether Taz has an active
role in regulation of hematopoeisis and HSCs. Indeed, our
preliminary observations suggest that Taz is expressed at relatively
high levels within the LT-HSC compartment but not in
progenitors and differentiated hematopoietic cells (Jansson and
Larsson unpublished observation).
In summary, our findings conclusively show that counteracting
Hippo signaling by enforced YAP1 expression does not alter in
vivo hematopoiesis or HSC function. More work will be required
to elucidate whether other aspects of Hippo signaling, directly or
indirectly, may influence hematopoietic cells, either through the
Yap paralog Taz, or through actions on neighboring non-
hematopoietic cells in the bone marrow microenvironment.
Supporting Information
Figure S1 (A) Chromatogram from sequencing of pBS31
targeting vector with the mutated version of YAP1 (YAP
mut). (B)
Featured are the three bases making up the Serine 127 to Alanine
conversion and the following two amino acids. (C) Intracellular
flow cytometric analysis demonstrating YAP1 overexpression in
ES cells with or without doxycycline and control FMO
(Fluorescence minus one) with secondary anti-rabbit DyLight
conjugated antibody.
(TIF)
Figure S2 Wildtype and mutant YAP1 constructs show
the expected phenotypes when induced in non-hemato-
poietic tissues. ES cells with inducible wildtype YAP1 were
injected into W41 blastocysts and YAP1 chimeric mice (n=3) and
wildtype control mice (n=2) were administered doxycycline
during 46 days before they were sacrificed and the liver
appearance (A) and weight (B) examined. Upon doxycycline
induction YAP1 chimeric mice developed hepatomegaly in
accordance with known YAP functions in the liver (C) Germline
YAP
mut mice with generalized YAP overexpression were induced
with doxycycline in the drinking water. The graph shows percent
survival for induced YAP
mut mice (n=5) and littermate controls
(n=10). (D) Germline YAP
mut mice were induced with doxycy-
cline for 4 days and then sacrificed. Total liver cells were used for
RNA extraction, reverse transcription and RT qPCR. The
expression of YAP1 and the YAP1 response gene Birc5 was
measured. Error bars represent SEM for n=2.
(TIF)
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